News on Oncology continually updated from thousands of sources around the net.
1 hr ago | Freshnews
Biothera announced today that new data and insights for Imprime PGG, the company's investigational cancer immunotherapy drug, will be featured in three presentations, including a late-breaking abstract, at the European Society of Medical Oncology 2014 Congress on September 26-30 in Madrid. "We are excited to present cutting-edge data highlighting the significant therapeutic potential of Imprime PGG as a novel innate immune modulator in combination with targeted antibody therapy," said Ada Braun, M.D., Ph.D., Biothera chief medical officer.
5 hrs ago | KGNS-TV Laredo
A Texas oncologist was obsessed with and had a "fatal attraction" to her fellow physician lover, whose rejection prompted her to poison him by lacing his coffee with ethylene glycol, prosecutors said Monday as her aggravated assault trial began. "The evidence is going to show she became absolutely and totally obsessed," Justin Keiter, an assistant Harris County district attorney, said during opening arguments in the trial of Ana Maria Gonzalez-Angulo, 43, a breast cancer doctor based at Houston's famed Texas Medical Center.
6 hrs ago | KYTX-TV News
A common chemical found in many household products may not be healthy for pregnant women and their children. Phthalates are used in fragrances, plastic food containers, vinyl floors and shower curtains.
CITY scientists have discovered why a gene fault could put one in six people at a higher risk of cancer. This could put people at a higher risk of a contracting a number of cancers, including breast, cervical and lung cancer, they said.
The public appeal, the biggest in the history of Colchester General Hospital, aims to raise enough money to bring cancer services - including chemo and radiotherapy together. It would also have facilities to help cancer patients and their families come to terms with the life-threatening illness - and help them have a good quality of life once their treatment has been completed.
Treatment with endocrine therapy and radiation therapy as part of breast conservation is the current standard of care for women with hormone-receptor positive invasive breast cancer. A new study by researchers at Fox Chase Cancer Center, however, shows that combination may not be necessary for all patient populations with the disease.
A large, international analysis of patients with stage IV non-small cell lung cancer indicates that a patient's overall survival rate can be related to factors including the timing of when metastases develop and lymph node involvement, and that aggressive treatment for "low-risk" patients leads to a five-year OS rate of 47.8 percent, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting.
Non-small cell lung cancer survivors who never smoked or who are former smokers at the time of diagnosis have a lower risk of developing secondary primary lung cancers compared to those who are current smokers, suggesting that increased tobacco exposure is associated with a higher risk of SPLC, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. The analysis studied the association between patients ' smoking histories and their risks of developing SPLC, which is defined as a new lung cancer unrelated to the initial tumor based on histology and location in the lung.
Radiation therapy alone is as effective in decreasing swallowing complications experienced by advanced esophageal cancer patients as RT combined with chemotherapy, thus allowing patients to forgo chemotherapy, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. In this international study that included sites in Australia, New Zealand, Canada and the United Kingdom, researchers assessed the use of palliative chemotherapy combined with RT, or chemoradiotherapy , to provide relief from dysphagia .
Combining a standard chemotherapy drug with a second drug that stops cells from dividing improves both the survival and response rates for those with advanced cervical cancer , a new study by UT Southwestern Medical Center cancer researchers finds. The cancer-fighting cocktail, which combines the chemotherapy drug cisplatin with pemetrexed - an agent that stops cancer cells from dividing - showed promising results for advanced, persistent, or recurrent cervical cancer.
Men with a certain pattern of baldness at age 45 had a 39% increased risk of developing aggressive prostate cancer versus men with no baldness, a new U.S. study found. Men with frontal baldness and moderate baldness on the crown of the head had a higher risk of developing an aggressive form of prostate cancer.
Dr. Ana Maria Gonzalez-Angulo sits in court on the first day of her trial on a felony charge of aggravated assault,at the Harris County Criminal Justice Center Monday, Sept.
Good afternoon everyone. My name is Kyla and I will be your conference operator today.
Adding chest radiation to chemotherapy allows some people with small-cell lung cancer to live longer and cuts recurrence rates by nearly 50 percent, European researchers report. Based on the results of a four-country study, the researchers recommended that chest radiotherapy be routinely offered to patients with advanced small-cell lung cancer who respond to chemotherapy.
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
I'm a writer, physician and breast cancer survivor. Earlier in my career I practiced oncology and hematology.
The trial for a Texas cancer researcher accused of poisoning her jilted lover's coffee with a colorless and odorless chemical found in antifreeze begins Monday. Dr. Ana Maria Gonzalez-Angulo allegedly poisoned fellow cancer researcher Dr. George Blumenschein, according to officials.
Updated: Wed Sep 17, 2014 01:17 pm
Copyright © 2014 Topix LLC